vimarsana.com
Home
Live Updates
Tarlatamab Shows Promise in Tackling Previously Treated SCLC : vimarsana.com
Tarlatamab Shows Promise in Tackling Previously Treated SCLC
The investigational drug led to encouraging overall survival and intracranial disease control in patients with small-cell lung cancer, longer-term trial data suggested.
Related Keywords
London ,
City Of ,
United Kingdom ,
Mainfranken ,
Bayern ,
Germany ,
Italy ,
Horst Dieter Hummel ,
Tom Newsom Davis ,
Cancer Center Mainfranken ,
European Lung Cancer Congress ,
Comprehensive Cancer Center Mainfranken ,
Jessica Menis ,
Oncology Department ,
University Hospital ,
Westminster Hospital ,
vimarsana.com © 2020. All Rights Reserved.